Jan Marini Skin Research (JMSR) is a pioneering force in the realm of medically validated skin care and aesthetic products for professionals, catering primarily to Physicians, PA’s, RN’s, and licensed estheticians. Founded in 1994, the company has been at the forefront of revolutionary product solutions, including being the first to introduce Glycolic Acid in skincare and develop a stable topical Vitamin C product years before it hit the mainstream market. Additionally, in 2005, JMSR brought to market a cosmetic eyelash enhancement conditioner, which has since transformed the industry, spearheading a popular beauty category.
Under the leadership of Jan Marini, the founder and Chairman of the Board, the company has garnered acclaim for its commitment to developing proprietary formulas that showcase measurable clinical results and benefits. Marini, a respected figure in the international skincare arena, has spent over three decades researching and developing cutting-edge technologies used in the products, forging associations with leading physicians and research scientists. Her influence extends beyond the company as she has been a notable keynote speaker at international tradeshows and medical conferences, focusing on technological innovation in skincare, and has frequently appeared in the media as an industry expert.
Headquartered in the United States, JMSR operates via a direct sales organization in the US and employs independent distributors worldwide. With a keen focus on Consumer Goods, Health Care, and Manufacturing industries, Jan Marini Skin Research stands as an influential player in the professional skincare market, holding promise for potential investors seeking impactful opportunities within the beauty and wellness sector. Currently, there is no public information available about the last investment or the involved investors.
There is no investment information
No recent news or press coverage available for Jan Marini Skin Research.